z-logo
open-access-imgOpen Access
Tetrandrine Inhibits Epithelial-Mesenchymal Transition in IL-6-Induced HCT116 Human Colorectal Cancer Cells
Author(s) -
ShihChang Tsai,
Wei-Chei Wu,
Jai Sing Yang
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s324552
Subject(s) - tetrandrine , mtt assay , viability assay , gentamicin protection assay , epithelial–mesenchymal transition , cell migration , colorectal cancer , cell culture , cancer research , cell , metastasis , microbiology and biotechnology , cancer cell , chemistry , biology , cancer , pharmacology , biochemistry , genetics
Patients with colorectal cancer (CRC) often develop distant metastases, which significantly reduces the 5-year survival rate. Epithelial-mesenchymal transition (EMT) is a crucial process for the invasion and metastasis of cancer cells. Tetrandrine has been reported to inhibit the viability and EMT of CRC cells; however, to the best of our knowledge, the molecular mechanism remains undetermined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here